Manufacturers Life Insurance Company, The Vera Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 101,861 shares of VERA stock, worth $4.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
101,861
Previous 102,037
0.17%
Holding current value
$4.22 Million
Previous $3.69 Million
21.95%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VERA
# of Institutions
184Shares Held
55.2MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$178 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$163 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$138 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$123 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$116 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.12B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...